Willier, S., Cabanillas Stanchi, K. M., von Have, M., Binder, V., Blaeschke, F., Feucht, J., . . . Döring, M. (2019). Efficacy, safety and feasibility of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric patients receiving moderately and highly emetogenic chemotherapy – results of a non-interventional observation study. BMC Cancer.

Willier, Semjon, Karin Melanie Cabanillas Stanchi, Martina von Have, Vera Binder, Franziska Blaeschke, Judith Feucht, Tobias Feuchtinger, and Michaela Döring. "Efficacy, Safety and Feasibility of Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Patients Receiving Moderately and Highly Emetogenic Chemotherapy – Results of a Non-interventional Observation Study." BMC Cancer 2019.

Willier, Semjon, et al. "Efficacy, Safety and Feasibility of Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Patients Receiving Moderately and Highly Emetogenic Chemotherapy – Results of a Non-interventional Observation Study." BMC Cancer 2019.